Walleye Capital LLC Replimune Group, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $97,710 - $184,498	19,503 Added 64.47%	49,754 $447,000
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $1,325 - $1,796	193 Added 0.64%	30,251 $247,000
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $202,891 - $486,338	30,058 New	30,058 $253,000
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $792,875 - $1.22 Million	50,663 New	50,663 $1.18 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.